Back
Zoetis 10K Form
Sell
36
ZTS
Zoetis
Last Price:
164.40
Seasonality Move:
0.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | ZTS/Zoetis Quarterly |
| 2023-11-02 | 10Q | ZTS/Zoetis Quarterly |
| 2023-08-08 | 10Q | ZTS/Zoetis Quarterly |
| 2023-05-04 | 10Q | ZTS/Zoetis Quarterly |
| 2022-11-03 | 10Q | ZTS/Zoetis Quarterly |
| 2022-08-04 | 10Q | ZTS/Zoetis Quarterly |
Receive ZTS News And Ratings
See the #1 stock for the next 7 days that we like better than ZTS
ZTS Financial Statistics
Sales & Book Value
| Annual Sales: | $8.54B |
|---|---|
| Cash Flow: | $784M |
| Price / Cash Flow: | 33.82 |
| Annual Sales: | $11.59 |
| Price / Book: | 14.72 |
Profitability
| EPS (TTM): | 5.32000 |
|---|---|
| Net Income (TTM): | $2.43B |
| Gross Margin: | $5.98B |
| Return on Equity: | 48% |
| Return on Assets: | 17.05% |
Zoetis Earnings Forecast
Key Zoetis Financial Ratios
- The Gross Profit Margin over the past 15 years for ZTS is 70.03%.
- The Selling, General & Administrative Expenses for ZTS have been equal to 25.18% of Gross Profit Margin.
- The Research & Development expenses have been 7.19% of Revenue.
- The Interest Expense is 10.20% of Operating Income.
- The Net Earning history of ZTS is 27.43% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 13 years.
Zoetis Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ZTS |
| CUSIP: | 98978V |
| Website: | zoetis.com |
Debt
| Debt-to-Equity Ratio: | 1.26 |
|---|---|
| Current Ratio: | 3.69 |
| Quick Ratio: | 1.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 33.69 |
|---|---|
| Forward P/E Ratio: | 26.66 |